Premium
LncRNAs: New Players in Gliomas, With Special Emphasis on the Interaction of lncRNAs With EZH2
Author(s) -
Bian ErBao,
Li Jia,
Xie YongSheng,
Zong Gang,
Li Jun,
Zhao Bing
Publication year - 2015
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.24549
Subject(s) - glioma , epigenetics , ezh2 , microrna , dna methylation , angiogenesis , malignancy , biology , meg3 , cancer research , bioinformatics , computational biology , long non coding rna , neuroscience , downregulation and upregulation , genetics , gene expression , gene
Gliomas are the most common primary malignancy in the brain, accounting for 50–60%. Despite all the efforts of cytoreductive surgery in combination with intense chemoradiotherapy, glioma remains an incurable disease. Recent studies have shown that long noncoding RNAs (lncRNAs) are involved in the pathology of gliomas. LncRNAs are involved in many cellular processes, such as angiogenesis, invasion, cell proliferation, and apoptosis. In this review we focus on the dysregulation of lncRNAs in gliomas. We also address that epigenetic modification such as DNA methylation and microRNAs interact with lncRNAs in gliomas. In addition, the interaction of lncRNAs with signaling pathways in gliomas is discussed systematically, with particular emphasis on the interaction of lncRNAs with EZH2. Such approaches provide valuable insights into the potential future applications of lncRNAs in the treatment of gliomas. J. Cell. Physiol. 230: 496–503, 2015. © 2014 Wiley Periodicals, Inc., A Wiley Company